Eric P. Lefkofsky Sells 82,056 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 82,056 shares of the business’s stock in a transaction that occurred on Friday, January 31st. The stock was sold at an average price of $58.21, for a total transaction of $4,776,479.76. Following the completion of the transaction, the chief executive officer now directly owns 5,532,987 shares of the company’s stock, valued at $322,075,173.27. This trade represents a 1.46 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Tempus AI Stock Up 0.3 %

Shares of TEM opened at $57.39 on Monday. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The company’s fifty day moving average price is $44.18 and its 200-day moving average price is $48.29. Tempus AI, Inc. has a 1-year low of $22.89 and a 1-year high of $79.49.

Institutional Trading of Tempus AI

Several large investors have recently added to or reduced their stakes in the company. First Horizon Advisors Inc. acquired a new stake in shares of Tempus AI during the third quarter worth about $30,000. FNY Investment Advisers LLC acquired a new stake in Tempus AI during the 4th quarter valued at approximately $67,000. Vestor Capital LLC purchased a new stake in shares of Tempus AI in the 3rd quarter valued at $153,000. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Tempus AI in the 4th quarter valued at $178,000. Finally, Stifel Financial Corp purchased a new position in shares of Tempus AI during the third quarter worth $218,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on TEM shares. Needham & Company LLC restated a “buy” rating and set a $56.00 price objective on shares of Tempus AI in a research note on Tuesday, January 14th. Loop Capital decreased their price target on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a research report on Tuesday, January 14th. Wolfe Research began coverage on shares of Tempus AI in a research report on Friday, December 13th. They issued an “outperform” rating and a $60.00 price objective on the stock. Piper Sandler reissued a “neutral” rating and set a $70.00 target price (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Finally, Stifel Nicolaus lowered shares of Tempus AI from a “buy” rating to a “hold” rating and lifted their price target for the stock from $45.00 to $65.00 in a report on Monday, November 11th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat, Tempus AI currently has a consensus rating of “Moderate Buy” and an average price target of $56.36.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.